| Identification | Back Directory | [Name]
Redaporfin | [CAS]
1224104-08-8 | [Synonyms]
LUZ11
LUZ-11
LUZ 11
F2BMet
F-2BMet
F 2BMet
Redaporfin
Benzenesulfonamide, 3,3',3'',3'''-(7,8,17,18-tetrahydro-21H,23H-porphine-5,10,15,20-tetrayl)tetrakis[2,4-difluoro-N-methyl-
2,4-difluoro-N-methyl-3-[10,15,20-tris[2,6-difluoro-3-(methylsulfamoyl)phenyl]-2,3,12,13,22,24-hexahydroporphyrin-5-yl]benzenesulfonamide | [Molecular Formula]
C48H38F8N8O8S4 | [MDL Number]
MFCD30747924 | [MOL File]
1224104-08-8.mol | [Molecular Weight]
1135.11 |
| Hazard Information | Back Directory | [Uses]
Redaporfin (LUZ11) acts as a potent photosensitizer. Redaporfin causes direct antineoplastic effects as well as indirect immune-dependent destruction of malignant lesions[1]. | [References]
[1] Lígia C Gomes-da-Silva, et al. Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus. EMBO J. 2018 Jul 2;37(13):e98354. DOI:10.15252/embj.201798354 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
|